glp 1 lupus Risk of End-Stage Renal Disease Among Patients with Nephritis on GLP-1 Receptor Agonists: A Retrospective Cohort Study Microdosing GLP-1 for autoimmune conditions:

In 2024, a randomized, double-blinded phase 2 clinical trial published in eClinicalMedicine (Hansen et al.) followed 64 adults at increased fracture risk for 52 weeks on once-weekly semaglutide 1.0 mg versus placebo

Right now, GLP-1 for weight loss is very promising

As always, I encourage you to schedule a consultation so we can determine whether Calocurb is appropriate for your unique health needs and create a personalized plan that supports your longterm wellness

Focus on Protein When youre eating less, make every bite count

Supply : In 2025, supply bottlenecks will continue to ease following extensive efforts by Novo Nordisk and Lilly to step up manufacturing, with important implications for competitive dynamics: The large-scale opportunity for compounders will be closing